By Eva Kiesler, PhD, Science Writer/Editor | Monday, November 19, 2012
In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development.
In the News
By Julie Grisham, MS, Science Writer/Editor | Friday, November 16, 2012
Memorial Sloan Kettering has been praised for taking a stand on the price for a new cancer drug that costs more than twice as much as another, similar drug.
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor | Thursday, November 15, 2012
Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.
By Memorial Sloan Kettering | Monday, November 12, 2012
Dr. Shah, Chief of the Head and Neck Service, discusses how Memorial Sloan Kettering’s world-renowned head and neck surgeons partner with patients to select the most appropriate treatment plan.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Friday, November 9, 2012
A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Thursday, November 8, 2012
Memorial Sloan Kettering’s colorectal cancer team has developed online prediction tools that assess disease risk following surgery, enabling patients and physicians to make better treatment decisions.
By Andrea Peirce, BA, Writer/Editor | Tuesday, November 6, 2012
For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.
By Julie Grisham, MS, Science Writer/Editor | Friday, November 2, 2012
Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.
By Memorial Sloan Kettering | Wednesday, October 31, 2012
Dr. Huang discusses how minimally invasive, video-assisted, and robotic surgical techniques improve the treatment of patients with lung, esophageal, and thyroid cancers.
By Memorial Sloan Kettering | Thursday, October 25, 2012
Organizers expect this year to be the most successful yet for this national indoor team cycling event, which raises funds for rare cancer research at Memorial Sloan Kettering.
By Memorial Sloan Kettering | Monday, October 22, 2012
Dr. Abu-Rustum, Director of Minimally Invasive Surgery for the Gynecology Service, discusses how the gynecologic cancer care team treats each woman with an individualized approach.
By Memorial Sloan Kettering | Friday, October 19, 2012
Dr. DeAngelis has been elected to the Institute of Medicine (IOM), considered one of the highest honors in the field of health and medicine.
By Media Staff | Wednesday, October 17, 2012
Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.
By Andrea Peirce, BA, Writer/Editor | Monday, October 15, 2012
James had advanced melanoma and dwindling treatment options when his doctors enrolled him in a clinical trial of an innovative immunotherapy developed at Memorial Sloan Kettering.
In the News
By Media Staff | Thursday, October 11, 2012
Good Morning America co-host Robin Roberts recently said good-bye to her inpatient treatment team at Memorial Sloan Kettering after undergoing a stem cell transplant to treat myelodysplastic syndrome.